Artificial intelligence insulin delivery and glucose monitoring system cleared for age 6 and older While it won’t cure children of type 1 diabetes, the “bionic pancreas,” an artificial intelligence-powered system cleared Friday, May 19, by the U.S. Food and Drug Administration, will relieve youth and their parents of constant worries over estimating insulin doses and […]
Share This Story
The Max and Minnie Tomerlin Voelcker Fund is awarding $1.8 million to UT Health San Antonio to support research projects conducted by promising early career researchers.
Share This Story
An improvement in 6-month progression-free survival warrants additional study in a larger trial, researchers said. The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM). The Mays Cancer Center, one of the four National Cancer […]
Share This Story
Glioblastoma-impacted mice lived longer when treated with combination of molecule drug and chemotherapy agent Glioblastoma (GBM), a highly devastating brain tumor, has long posed challenges as effective treatments have remained elusive. Despite responding initially to treatment, GBM patients often experience therapy resistance leading to low long-term survival rates, with only 7.2% of patients surviving beyond […]
Share This Story
UT Health San Antonio President William L. Henrich, MD, MACP, was quoted in this article. Read Now
Share This Story
$100 million comprehensive research and patient care center will offer the latest advancing therapies for dementia and all neurologic disorders Amid a rising tsunami of needed care for dementia and other neurologic diseases, construction began this week on the $100 million Center for Brain Health, a new patient care and clinical trials facility of The […]
Share This Story
This spring, UT Health San Antonio announced it will build a $100 million Center for Brain Health to enhance its Biggs Institute and the Department of Neurology of its Joe R. and Teresa Lozano Long School of Medicine.
Share This Story
Doctoral student’s research suggests difficulty of translating longevity interventions from lower species to mammals If a drug extends the life span of worms or flies, is it likely to do the same in mice? Michael Bene, PhD student Not typically based on the existing data, said Michael Bene, a sixth-year doctoral student at The University […]
Share This Story
Protection is afforded infants against disease-causing bacteria Certain immune cells possess a homing property that directs them to the skin at birth to protect the baby, researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) discovered. “These T cells home in on the skin like a guided missile,” […]
Share This Story
<p>Researchers from UT Health San Antonio have developed a small-molecule drug that prevents weight gain and adverse liver changes in mice fed a high-sugar, high-fat Western diet throughout life.</p>
Share This Story